These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22663953)

  • 1. Severe neutropenia in a renal transplant patient suggesting an interaction between mycophenolate and fenofibrate.
    Alvarez PA; Egozcue J; Sleiman J; Moretti L; Di Girolamo G; Keller GA
    Curr Drug Saf; 2012 Feb; 7(1):24-9. PubMed ID: 22663953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil-induced agranulocytosis in a renal transplant recipient.
    Matsui K; Shibagaki Y; Sasaki H; Chikaraishi T; Yasuda T; Kimura K
    Clin Exp Nephrol; 2010 Dec; 14(6):637-40. PubMed ID: 20694498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limits to intensified mycophenolate mofetil dosing in kidney transplantation.
    Kiberd BA; Lawen J; Daley C
    Ther Drug Monit; 2012 Dec; 34(6):736-8. PubMed ID: 23007746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
    Tett SE; Saint-Marcoux F; Staatz CE; Brunet M; Vinks AA; Miura M; Marquet P; Kuypers DR; van Gelder T; Cattaneo D
    Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neutropenia suggesting an interaction between valacyclovir and mycophenolate mofetil.
    Royer B; Zanetta G; Bérard M; Davani S; Tanter Y; Rifle G; Kantelip JP
    Clin Transplant; 2003 Apr; 17(2):158-61. PubMed ID: 12709084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Perioperative agranulocytosis induced by immunosuppressants in a renal graft recipient : a case report].
    Matsumoto K; Kobayashi T; Murakami K; Okubo K; Negoro H; Terada N; Sugino Y; Yamasaki T; Matsui Y; Inoue T; Kamba T; Yoshimura K; Ogawa O
    Hinyokika Kiyo; 2014 Jun; 60(6):275-8. PubMed ID: 25001642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate-induced oral ulcers: Case report and literature review.
    Asare K; Gatzke CB
    Am J Health Syst Pharm; 2020 Mar; 77(7):523-528. PubMed ID: 32058566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil.
    Mourad M; Malaise J; Chaib Eddour D; De Meyer M; König J; Schepers R; Squifflet JP; Wallemacq P
    Clin Chem; 2001 Jan; 47(1):88-94. PubMed ID: 11148182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ulcers associated with mycophenolate mofetil use in a renal transplant recipient.
    Weng RR; Foster CE; Hsieh LL; Patel PR
    Am J Health Syst Pharm; 2011 Apr; 68(7):585-8. PubMed ID: 21411799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
    Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
    Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus: a switch option for mycophenolate mofetil-induced leukopenia in renal transplant recipients.
    Shin BC; Chung JH; Kim HL
    Transplant Proc; 2013 Oct; 45(8):2968-9. PubMed ID: 24157014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal quality of life improvement of renal transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium drugs or agents: mycophenolate mofetil and enteric-coated mycophenolate sodium.
    Ortega F; Sánchez-Fructuoso A; Cruzado JM; Gómez-Alamillo JC; Alarcón A; Pallardó L; Morales JM; Oliver J; Guinea G;
    Transplantation; 2011 Aug; 92(4):426-32. PubMed ID: 21760569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.
    Budde K; Glander P; Diekmann F; Dragun D; Waiser J; Fritsche L; Neumayer HH
    Transplant Proc; 2004 Mar; 36(2 Suppl):524S-527S. PubMed ID: 15041401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualization of mycophenolate mofetil dose in renal transplant recipients.
    van Hest RM; Hesselink DA; Vulto AG; Mathot RA; van Gelder T
    Expert Opin Pharmacother; 2006 Mar; 7(4):361-76. PubMed ID: 16503809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.
    Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J
    Transpl Immunol; 1997 Sep; 5(3):225-32. PubMed ID: 9402690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels.
    van Besouw NM; van der Mast BJ; Smak Gregoor PJ; Hesse CJ; IJzermans JN; van Gelder T; Weimar W
    Nephrol Dial Transplant; 1999 Nov; 14(11):2710-3. PubMed ID: 10534517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How delayed graft function impacts exposure to mycophenolic acid in patients after renal transplantation.
    van Gelder T; Silva HT; de Fijter H; Budde K; Kuypers D; Mamelok RD; Armstrong VW; Oellerich M
    Ther Drug Monit; 2011 Apr; 33(2):155-64. PubMed ID: 21383657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
    Staatz CE; Tett SE
    Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.